A Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Pharmacokinetic Profile of Voriconazole Inhalation Powder in Adult Subjects With Asthma
Latest Information Update: 28 Dec 2021
At a glance
- Drugs Voriconazole (Primary)
- Indications Asthma
- Focus Adverse reactions
- Sponsors TFF Pharmaceuticals
- 21 Dec 2021 Results published in the TFF Pharmaceuticals Media Release.
- 17 Nov 2021 Status changed from recruiting to completed.
- 08 Nov 2021 According to a TFF Pharmaceuticals media release, dosing of patients in this trial has been completed.